Intimation for Scrutinizer''s Report on postal ballot
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Limited has secured shareholder approval through a postal ballot (remote e-voting) conducted from December 1 to December 30, 2025. Two ordinary resolutions were passed with overwhelming majority: (1) the sub-division/split of equity shares received 99.9988% votes in favor, and (2) the alteration of the Capital Clause of the Memorandum of Association received 99.9986% votes in favor. Out of 8,263,700 total outstanding shares, 4,616,176 shares (55.86%) were polled. The promoter group voted unanimously in favor with all 4,609,504 polled shares, while public non-institutions showed 99.18% support. The Scrutinizer's Report was issued by Pankaj Kumar Gupta of PKG & Associates on December 31, 2025, confirming both resolutions were passed with requisite majority.
The approved stock split will increase the number of outstanding shares while proportionally lowering the per-share price, which typically improves affordability and trading liquidity for retail investors. Existing shareholders' total holding value remains unchanged, but the stock price will adjust downward once the split is implemented.